MeSH D009798 - ocular hypertension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Bimatoprost, Timolol | Ganfort | 2006-05-19 | |||
| Bimatoprost | Lumigan | 2002-03-08 | ||||
| Novartis | Brinzolamide, Timolol | Azarga | 2008-11-25 | |||
| Brinzolamide | Azopt | 2000-03-09 | ||||
| Travoprost, Timolol | DuoTrav | 2006-04-23 | ||||
| Travoprost | Izba | 2014-02-20 | ||||
| Brinzolamide, Brimonidine | Simbrinza | 2014-07-18 | ||||
| Travoprost | Travatan | 2001-11-27 | ||||
| Hospira | Mannitol, Sorbitol | Sorbitol-mannitol | 1982-01-01 | |||
| Santen | Netarsudil | Rhokiinsa | 2019-11-19 | |||
| Netarsudil, Latanoprost | Roclanda | 2021-01-07 | ||||
| Alcon Research | Levobetaxolol | Betaxon | 2000-02-23 | |||
| Netarsudil | Rhopressa | 2026-07-11 | 2017-12-18 | |||
| Netarsudil, Latanoprost | Rocklatan | 2026-07-11 | 2019-03-12 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%8/8
Phase 2
73%11/15
Phase 3
78%25/32
Approved: 11Overall Success rate: 57%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use